[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE0101220D0 - New use - Google Patents

New use

Info

Publication number
SE0101220D0
SE0101220D0 SE0101220A SE0101220A SE0101220D0 SE 0101220 D0 SE0101220 D0 SE 0101220D0 SE 0101220 A SE0101220 A SE 0101220A SE 0101220 A SE0101220 A SE 0101220A SE 0101220 D0 SE0101220 D0 SE 0101220D0
Authority
SE
Sweden
Prior art keywords
new use
glycoconjugates
colon
glucocorticosteroids
ibs
Prior art date
Application number
SE0101220A
Other languages
Swedish (sv)
Inventor
Ralph Brattsand
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0101220A priority Critical patent/SE0101220D0/en
Publication of SE0101220D0 publication Critical patent/SE0101220D0/en
Priority to PCT/SE2002/000662 priority patent/WO2002080931A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to the use of glycoconjugates of glucocorticosteroids (GC) as a targeting to the colon, for example to colon of patients with irritable bowel syndrome (IBS), and pharmaceutical compositions containing said glycoconjugates.
SE0101220A 2001-04-04 2001-04-04 New use SE0101220D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0101220A SE0101220D0 (en) 2001-04-04 2001-04-04 New use
PCT/SE2002/000662 WO2002080931A1 (en) 2001-04-04 2002-04-02 New use of glyconjugates of glucocorticosteroids as a targeting to the colon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0101220A SE0101220D0 (en) 2001-04-04 2001-04-04 New use

Publications (1)

Publication Number Publication Date
SE0101220D0 true SE0101220D0 (en) 2001-04-04

Family

ID=20283686

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0101220A SE0101220D0 (en) 2001-04-04 2001-04-04 New use

Country Status (2)

Country Link
SE (1) SE0101220D0 (en)
WO (1) WO2002080931A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL307357A (en) 2016-11-08 2023-11-01 Regeneron Pharma Steroids and protein-conjugates thereof
US11491237B2 (en) 2017-05-18 2022-11-08 Regeneron Pharmaceuticals, Inc. Cyclodextrin protein drug conjugates
IL313068A (en) 2017-11-07 2024-07-01 Regeneron Pharma Hydrophilic linkers for antibody drug conjugates
MX2020006994A (en) 2018-01-08 2020-11-06 Regeneron Pharma Steroids and antibody-conjugates thereof.
WO2019217591A1 (en) 2018-05-09 2019-11-14 Regeneron Pharmaceuticals, Inc. Anti-msr1 antibodies and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ259596A (en) * 1993-01-08 1997-04-24 Astra Ab Sugar-substituted glucocorticosteroid and use in medicaments specific to the colon or ileum

Also Published As

Publication number Publication date
WO2002080931A1 (en) 2002-10-17

Similar Documents

Publication Publication Date Title
EA200300937A1 (en) ORAL PHARMACEUTICAL COMPOSITION OF CEFPODOXIMA PROXETYL
SE0301700D0 (en) Novel compounds
SE0301653D0 (en) Novel compounds
NO20070224L (en) 2-urea-4-phenylthiazole derivatives, preparation and therapeutic use thereof
BRPI0417717A (en) compound, pharmaceutical composition, and use of a compound
BR9917007A (en) Ccr5 modulators
IS6658A (en) New compounds
CY1111470T1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLYVERSERIN POLYMORPH A
TR200200768T2 (en) New quinuclide derivatives and drug compositions containing it
SE0001899D0 (en) New compounds
DE60225040D1 (en) MONTELUKAST GRANULES Formulation
BR0214343A (en) 11 - Beta - Hydroxy Steroid Dehydrogenase Inhibitors Type 1
EA200401526A1 (en) NEW CONNECTIONS AND THEIR APPLICATION
CY1111567T1 (en) INTERMEDIATE DIVENZO (B, F) AZEPINIS
PA8575601A1 (en) PROCEDURE FOR PREPARATION, MEDICATIONS THAT INCLUDE THESE COMPOUNDS AND THEIR USE
TNSN06012A1 (en) Emulsifying systems containing azetidine derivatives
SE9901077D0 (en) Novel use
NO20043016L (en) 6-aminomorphinan derivatives, process for preparation and use thereof
SE0102716D0 (en) Novel compounds
SE9804212D0 (en) Compounds
MXPA05008960A (en) Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them.
SE9801494D0 (en) Novel use
EA200300727A1 (en) DERIVATIVES OF 2H-1-BENZOPIRANE, METHODS OF THEIR PRODUCTION AND THEIR PHARMACEUTICAL COMPOSITIONS
EE200200252A (en) Use of Antibodies as Vaccines; Pharmaceutical Compositions Containing Antibodies;
CY1105798T1 (en) STEPOIDS, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THEREOF AND USES OF THE COMPOUNDS